A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy Subject

NCT05147259 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes in Adults

Interventions

DRUG: HR011408 injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.